Jeffrey Frelick's most recent trade in Bone Biologics Corp was a trade of 54,110 Employee Stock Option done . Disclosure was reported to the exchange on Jan. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bone Biologics Corp | Jeffrey Frelick | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 54,110 | 54,110 | - | - | Employee Stock Option | |
| Bone Biologics Corp | Jeffrey Frelick | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 25,000 | 25,000 | - | - | Employee Stock Option | |
| Bone Biologics Corp | Jeffrey Frelick | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 37,750 | 140,140 | - | - | Employee Stock Option | |
| Bone Biologics Corp | Jeffrey Frelick | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 50,000 | 102,389 | - | - | Employee Stock Option |